Your browser doesn't support javascript.
loading
Directions to overcome therapy resistance in cancer.
Nussinov, Ruth; Weichhart, Thomas; Dlamini, Zodwa; Gibbons, Don L; Van Seuningen, Isabelle; Konen, Jessica; Ju, Huai-Qiang.
Afiliación
  • Nussinov R; Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA; Cancer Innovation Laboratory, National Cancer Institute at Frederick, Frederick, MD 21702, USA; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine,
  • Weichhart T; Institute for Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Währinger Straße 10, 1090 Vienna, Austria. Electronic address: thomas.weichhart@meduniwien.ac.at.
  • Dlamini Z; SAMRC Precision Oncology Research Unit (PORU), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0028, South Africa. Electronic address: zodwa.dlamini@up.ac.za.
  • Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: Dlgibbon@mdanderson.org.
  • Van Seuningen I; University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France. Electronic address: isabelle.vanseuningen@inserm.fr.
  • Konen J; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA. Electronic address: Jessica.marie.konen@emory.edu.
  • Ju HQ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Sun Yat-sen University, Guangzhou 510060, PR China. Electronic address: juhq@sysucc.org.cn.
Trends Pharmacol Sci ; 45(6): 467-471, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38760267
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Trends Pharmacol Sci Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Trends Pharmacol Sci Año: 2024 Tipo del documento: Article